Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Suryamas Dutamakmur Tbk. (SMDM)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Suryamas Dutamakmur Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Suryamas Dutamakmur Tbk. diperdagangkan di Rp550 (kapitalisasi pasar 2,62 T, volume 24 jam 50,2 rb). Perbedaan utamanya: Suryamas Dutamakmur Tbk. jauh lebih besar — sekitar 25,1× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SMDM | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 2,62 T |
Volume | — | 50,2 rb |
Lot | — | 502 |
Perputaran | — | 26,74 jt |
Harga Rata-rata | — | 532,67 |
Nilai Transaksi | — | 26,74 jt |
Harga Ekuilibrium Indikatif | — | 550 |
Volume Ekuilibrium Indikatif | — | 2 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Suryamas Dutamakmur Tbk.
PT Suryamas Dutamakmur Tbk (the Company) was established based on notarial Deed No. 322, dated September 21, 1989 of Benny Kristianto, S.H., notary in Jakarta. PT. Suryamas Dutamakmur has a specific aim to participate in meeting the growing demand for quality residential development in the Greater Jakarta area.
Selengkapnya di halaman SMDM →
